Last reviewed · How we verify
Sustained iron dextran supplementation — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Sustained iron dextran supplementation (Sustained iron dextran supplementation) — Shanghai East Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sustained iron dextran supplementation TARGET | Sustained iron dextran supplementation | Shanghai East Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sustained iron dextran supplementation CI watch — RSS
- Sustained iron dextran supplementation CI watch — Atom
- Sustained iron dextran supplementation CI watch — JSON
- Sustained iron dextran supplementation alone — RSS
Cite this brief
Drug Landscape (2026). Sustained iron dextran supplementation — Competitive Intelligence Brief. https://druglandscape.com/ci/sustained-iron-dextran-supplementation. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing